Discovery and development of targeted therapeutics using AI-assisted computational platform
Discovery and development of targeted therapeutics using AI-assisted computational platform
Signed in as:
filler@godaddy.com
Discovery and development of targeted therapeutics using AI-assisted computational platform
Discovery and development of targeted therapeutics using AI-assisted computational platform
Akttyva Therapeutics, Inc. is a drug-discovery company founded by a team of pharmaceutical industry veterans, computational and experscientists and entrepreneurs to accelerate drug development. Our drug-discovery platform, AIDE, has won numerous awards, most notably, National Science Foundation, IBM and MassChallenge.
Akttyva Therapeutics co-founders have developed an evidence-based drug-discovery platform based on decades of expertise in biology, drug discovery and computational science. The platform is based on integrated drug-discovery tools and physics-based approaches, unique libraries of drug-like molecules and an experimental confirmation of predictions to bring new therapies to patients at an accelerated pace.
Akttyva is developing therapies for a number of unmet needs such as cancer, conditions with vascular leakage pathologies and a rare neurodegenerative disorder. Contact us to find out more.
Please reach out to us: +1-617-821-7095
155 Arlington Street, Watertown, Massachusetts 02472, United States